Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIITerminatedJul 23, 2014VelivetFailed Impurities/Degradation Specifications: out of specification impurity test results.Teva Pharmaceuticals USA · D-1439-2014Class IIITerminatedJul 23, 2014Kariva (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets 0.15 mg/0.02 mg and 0.01 mgFailed Impurities/Degradation Specifications: out of specification impurity test results.Teva Pharmaceuticals USA · D-1438-2014Class IIITerminatedJul 23, 2014MircetteFailed Impurities/Degradation Specifications: out of specification impurity test results.Teva Pharmaceuticals USA · D-1437-2014Class IIITerminatedJul 23, 2014Apri (desogestrel and ethinyl estradiol tablets USP)Failed Impurities/Degradation Specifications: out of specification impurity test results.Teva Pharmaceuticals USA · D-1436-2014Class IIITerminatedJul 23, 2014Diltiazem HCl Extended-release CapsulesFailed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · D-1435-2014Class IITerminatedJul 23, 2014Hemo-Stat SolutionMarketed without an Approved NDA/ANDA; product is being manufactured and distributed without a NDC numberAxcentria Pharmaceuticals, LLC · D-1434-2014Class IITerminatedJul 23, 2014Fentanyl Citrate InjectionLack of Assurance of Sterility: Fliptop vial crimps are loose or missing.Hospira Inc. · D-1433-201Class IIITerminatedJul 23, 2014LORTUSS EXDoes Not Meet Monograph: Phenylephrine and pseudoephedrine are below monograph specifications, and label inaccurately contains wording "Rx Only".Poly Pharmaceuticals, Inc · D-1432-2014Class IIITerminatedJul 23, 2014POLY-TUSSIN AC LIQUIDDoes Not Meet Monograph: Phenylephrine and pseudoephedrine are below monograph specifications, and label inaccurately contains wording "Rx Only".Poly Pharmaceuticals, Inc · D-1431-2014Class IITerminatedJul 16, 2014Fluvastatin Capsules USPFailed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint...Teva Pharmaceuticals USA · D-1430-2014Class IITerminatedJul 16, 2014Fosphenytoin Sodium InjectionPresence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.Fresenius Kabi USA, LLC · D-1429-2014Class IITerminatedJul 16, 2014Fosphenytoin Sodium InjectionPresence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.Fresenius Kabi USA, LLC · D-1428-2014Class IITerminatedJul 16, 2014Calcitriol Oral Solution 1 mcg/mLFailed Impurity/Degradation Specification; out of specification for trans-calcitriol degradant at the 9 month stability time pointBoehringer Ingelheim Roxane Inc · D-1427-2014Class IIITerminatedJul 16, 2014ENDOMETRINDiscoloration; due to prolonged heat exposure.Ferring Pharmaceuticals Inc · D-1426-2014Class IITerminatedJul 16, 2014Heparin Sodium in 5% Dextrose InjectionLack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.Hospira Inc. · D-1425-2014Class IITerminatedJul 16, 2014Labetalol Hydrochloride InjectionPresence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solutionHospira Inc. · D-1424-2014Class IITerminatedJul 16, 2014Tyvaso (treprostinil) Inhalation SolutionDefective Delivery System: United Therapeutics is voluntarily recalling a small number of Tyvaso Inhalation Systems with Optineb ON-100/7 and TD-100/A medical devices...United Therapeutics Corp. · D-1423-2014Class IITerminatedJul 16, 2014BUPivacaine HCl 0.25% Preservative FreePresence of Particulate Matter: The bupivacaine HCl injection used to compound this lot of BUPivacaine HCl 0.25% Preservative Free 500 mL in On-Q C-bloc was recalled by...Healix Infusion Therapy, Inc. · D-1422-2014Class IITerminatedJul 9, 2014HCG (Human Chorionic Gonadotropin) + MethylcobalaminIncorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.Brookfield Prescription Center Inc. dba MD Custom Rx · D-1421-2014Class IITerminatedJul 9, 2014HCG (Human Chorionic Gonadotropin) 200 units/ 0.1 mL dropsIncorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.Brookfield Prescription Center Inc. dba MD Custom Rx · D-1420-2014Class IITerminatedJul 9, 2014HCG 125U/Tab Tablet TrituIncorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.Brookfield Prescription Center Inc. dba MD Custom Rx · D-1419-2014Class IITerminatedJul 9, 2014HCG (Human Chorionic Gonadotropin) 125 units/ 0.1 mL dropIncorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.Brookfield Prescription Center Inc. dba MD Custom Rx · D-1418-2014Class IITerminatedJul 9, 2014DiphenhydramineIncorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.Brookfield Prescription Center Inc. dba MD Custom Rx · D-1417-2014Class IITerminatedJul 9, 2014Mometasone 0.6 mg /60 mL Irrigation solutionIncorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.Brookfield Prescription Center Inc. dba MD Custom Rx · D-1416-2014Class IITerminatedJul 9, 2014Venlafaxine Hydrochloride Extended-Release TabletsFailed Dissolution Specifications: Stability results found the product did not meet the drug dissolution specifications.Caraco Pharmaceutical Laboratories, Ltd. · D-1415-2014Class IITerminatedJul 9, 2014Isoniazid TabletsFailed Dissolution Specifications: Stability lots cannot support dissolution past the 36 month time point.West-Ward Pharmaceutical Corp. · D-1414-2014Class IITerminatedJul 9, 2014Brevibloc Premixed InjectionPresence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.Baxter Healthcare Corp. · D-1413-2014Class IITerminatedJul 9, 2014BystolicFailed Dissolution Specifications: Drug failed stage III dissolution testing.Forest Pharmaceuticals Inc · D-1412-2014Class IITerminatedJul 2, 2014Sodium Chloride Hypertonicity Ophthalmic OintmentCrystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.Bausch & Lomb, Inc. · D-1411-2014Class IITerminatedJul 2, 2014Muro 128Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.Bausch & Lomb, Inc. · D-1410-2014Class IITerminatedJul 2, 2014PristiqPresence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a...Pfizer Us Pharmaceutical Group · D-1409-2014Class IITerminatedJul 2, 2014Dextroamphetamine Sulfate TabletsFailed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.Teva Pharmaceuticals USA · D-1408-2014Class IITerminatedJul 2, 2014Gemcitabine For Injection USPLack of Assurance of Sterility: A particle excursion for a different batch of the same product may lead to a lack of sterility assurance.Caraco Pharmaceutical Laboratories, Ltd. · D-1407-2014Class IITerminatedJun 25, 2014Polidocanol 1% Solution for InjectionLack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.John W Hollis Inc · D-1406-2014Class IITerminatedJun 25, 2014PYRIDOXINE HCLLack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.John W Hollis Inc · D-1405-2014Class IITerminatedJun 25, 2014LIPOTROPIC GOLDLack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.John W Hollis Inc · D-1404-2014Class IITerminatedJun 25, 2014Papaverine HCl 30 mgLack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.John W Hollis Inc · D-1403-2014Class IITerminatedJun 25, 2014Papaverine HCl 30 mgLack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.John W Hollis Inc · D-1402-2014Class IITerminatedJun 25, 2014Papaverine HCl 30 mgLack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.John W Hollis Inc · D-1401-2014Class IITerminatedJun 25, 2014Papaverine HCl 30 mgLack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.John W Hollis Inc · D-1400-2014